within Pharmacolibrary.Drugs.ATC.D;

model D06BB10
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0008333333333333334,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.14,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06BB10</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Imiquimod is an immune response modifier used topically for the treatment of various dermatological conditions such as actinic keratosis, superficial basal cell carcinoma, and external genital warts. It is approved and widely used in clinical practice for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult humans following topical administration, as clinical absorption is minimal and most studies report limited systemic exposure.</p><h4>References</h4><ol><li><p>Zhang, B, et al., &amp; Lim, SK (2021). Topical Application of Mesenchymal Stem Cell Exosomes Alleviates the Imiquimod Induced Psoriasis-Like Inflammation. <i>International journal of molecular sciences</i> 22(2) –. DOI:<a href=\"https://doi.org/10.3390/ijms22020720\">10.3390/ijms22020720</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33450859/\">https://pubmed.ncbi.nlm.nih.gov/33450859</a></p></li><li><p>Alegre-Sánchez, A, et al., &amp; Boixeda, P (2018). Laser-Assisted Drug Delivery. <i>Actas dermo-sifiliograficas</i> 109(10) 858–867. DOI:<a href=\"https://doi.org/10.1016/j.ad.2018.07.008\">10.1016/j.ad.2018.07.008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30266385/\">https://pubmed.ncbi.nlm.nih.gov/30266385</a></p></li><li><p>Love, WE, et al., &amp; Bordeaux, JS (2009). Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. <i>Archives of dermatology</i> 145(12) 1431–1438. DOI:<a href=\"https://doi.org/10.1001/archdermatol.2009.291\">10.1001/archdermatol.2009.291</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20026854/\">https://pubmed.ncbi.nlm.nih.gov/20026854</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06BB10;
